Phase Ib Clinical Study of HDM1005 Injection
Clinical trial NCT06637020 · COMPLETED
Trial details
- NCT number
- NCT06637020
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2024-12-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.